🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study adopted a single-center, randomized, double-blind, placebo-contr...
Status
Completed
Location
Beijing Anzhen Hospital, Capital Medical University
Start Date
2025-08-06
Trial ID
NCT07083362
Treatments Being Tested
EXCELLENT was a prospective, multicenter, randomized, double-blind, placebo...
Status
Recruiting
Location
Beijing Tiantan Hospital of Capital Medical University
Start Date
2024-08-01
Trial ID
NCT07119021
Treatments Being Tested
Study on the Safety, Tolerance and Pharmacokinetics of Single-dose, Increas...
Status
Completed
Location
Beijing Tiantan Hospital, Capital Medical University
Start Date
2019-06-05
Trial ID
NCT04219865
pending...
Status
Unknown
Location
Multiple Locations
Start Date
2021-03-01
Trial ID
NCT04714177
Treatments Being Tested
To evaluate the pharmacokinetics safety, and tolerability of single and mul...
Status
Completed
Location
Investigational Site
Start Date
2018-03-20
Trial ID
NCT04481750
Treatments Being Tested
SIM0308-302 is a multicenter, randomized, double-blind, placebo-controlled ...
Status
Unknown
Location
Multiple Locations
Start Date
2023-12-28
Trial ID
NCT06176781
Treatments Being Tested
The primary objective of this study is to confirm the efficacy of 60 mg of ...
Status
Completed
Location
Multiple Locations
Start Date
2006-05-31
Trial ID
NCT00330681
Treatments Being Tested
To evaluate and compare the efficacy of two dosing regimens of oral edaravo...
Status
Terminated
Location
Woodland Research Northwest, LLC
Start Date
2022-01-11
Trial ID
NCT05151471
The primary objective of this study was to evaluate the efficacy and safety...
Status
Unknown
Location
Brain Hospital of Hunan Province
Start Date
2023-07-01
Trial ID
NCT05885919
Treatments Being Tested
Multicenter, multinational, double-blind, randomized (2:1), placebo-control...
Status
Completed
Location
University Hospitals Leuven
Start Date
2021-10-18
Trial ID
NCT05178810